YARROW BIOSCIENCE, INC. Prepaid Expense and Other Assets, Current
YARROW BIOSCIENCE, INC. (YARW) had Prepaid Expense and Other Assets, Current of $601.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets, Current $601.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $861.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.00M.
- 2025-06-30: Prepaid Expense and Other Assets, Current $4.70M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $601.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $861.00K S-4/A · filed 2026-06-03 | |
| 2025-12-31 | $1.00M 10-Q · filed 2026-08-13 | |
| 2025-06-30 | $4.70M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $4.64M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $2.92M S-4/A · filed 2026-06-03 | |
| 2024-09-30 | $3.30M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $5.63M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $4.22M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $2.66M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $1.76M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.02M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.64M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.30M 10-K · filed 2024-03-01 | $2.13M 10-K · filed 2023-03-14 |
| 2022-09-30 | $3.00M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.77M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $3.90M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $4.57M 10-K · filed 2023-03-14 | $5.12M 10-K · filed 2022-03-17 |
| 2021-09-30 | $5.06M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $5.27M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $3.87M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $4.59M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $3.47M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.67M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $4.24M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.56M 10-K · filed 2021-03-04 | $1.38M 10-K · filed 2020-03-03 |
| 2019-09-30 | $2.07M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $3.72M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $3.71M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $3.25M 10-K · filed 2020-03-03 | |
| 2018-09-30 | $1.81M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $2.31M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $3.59M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $3.57M 10-K · filed 2019-02-28 | |
| 2016-12-31 | $632.00K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |